Poor SH, Weissgerber G, Adams CM, Harit Bhatt, et al. A randomized, double-masked, multicenter trial of topical acrizanib (LHA510), a tyrosine kinase VEGF-receptor inhibitor, in treatment-experienced subjects with neovascular age-related macular degeneration. Am J Ophthalmol 2022 Mar 2. pii: S0002-9394(22)00084.
PMID: 35247334